{
  "pmid": "41536906",
  "title": "Pathogenic mechanisms of amyotrophic lateral sclerosis-linked VAPB P56S mutation in the degeneration of corticospinal motor neurons.",
  "abstract": "The endoplasmic reticulum (ER)-localized vesicle-associated membrane protein-associated protein B (VAPB) is implicated in many cellular processes, such as ER-organelle tethering, calcium homeostasis, and unfolded protein response. The P56S missense mutation in VAPB has been associated with familial forms of motor neuron diseases such as typical amyotrophic lateral sclerosis (ALS), atypical ALS, and spinal muscular atrophy. However, it has not been determined how the VAPB P56S mutation induces the degeneration of corticospinal motor neurons (CSMNs) in ALS. Using homozygous knock-in (KI) mice expressing P56S VAPB, we investigated the mutation's pathogenic impacts and underlying mechanisms on the survival and function of CSMNs. We performed a wide variety of assays to examine the behavioral, histological, cellular, and molecular abnormalities of KI mice. Compared with wild-type controls, KI mice showed the downregulated protein level of mutant VAPB, proteinase K-resistant cytoplasmic inclusions of mutant VAPB in CSMNs, abnormal hyperactivity, impaired motor coordination, neuronal loss of CSMNs, and axonal degeneration of pyramidal and corticospinal tracts. Mechanistic studies revealed that the VAPB P56S mutation rendered the mutant protein destabilized and inclusion-prone in cortical neurons, and the proteasomal degradation played a critical role in modulating mutant VAPB's protein level and inclusion formation. In addition, the VAPB P56S mutation disrupted ER-mitochondria contacts, impaired VAPB-PTPIP51 interaction and IP3R-VDAC interaction, elevated cytosolic Ca, activated CaMKII, and increased CRMP2 phosphorylation. Moreover, the VAPB P56S mutation activated the IRE1-XBP1/p38 mitogen-activated protein kinase (MAPK)/ c-Jun N-terminal kinase (JNK) pathway, increased tau hyperphosphorylation, and upregulated p53 expression and phosphorylation. These findings demonstrate the progressive degeneration of CSMNs induced by VAPB P56S mutation and indicate the involvement of the Ca-CaMKII-CRMP2 and IRE1-p38 MAPK/JNK-tau/p53 pathways in the pathogenic process.",
  "journal": "Ageing and neurodegenerative diseases",
  "year": "2025",
  "authors": [
    {
      "lastName": "Yang",
      "foreName": "Xuan",
      "initials": "X",
      "affiliation": ""
    },
    {
      "lastName": "Zheng",
      "foreName": "Jiayin",
      "initials": "J",
      "affiliation": ""
    },
    {
      "lastName": "Wang",
      "foreName": "Xinyu",
      "initials": "X",
      "affiliation": ""
    },
    {
      "lastName": "Cai",
      "foreName": "Huaibin",
      "initials": "H",
      "affiliation": ""
    },
    {
      "lastName": "Yu",
      "foreName": "Jia",
      "initials": "J",
      "affiliation": ""
    }
  ],
  "keywords": [
    "Vesicle-associated membrane protein-associated protein B (VAPB)",
    "amyotrophic lateral sclerosis (ALS)",
    "corticospinal motor neuron (CSMN)",
    "mutation",
    "neurodegeneration"
  ],
  "doi": "10.20517/and.2025.21",
  "pmcId": "PMC12797193",
  "meshTerms": [],
  "rawXml": "<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2025//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd\">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">41536906</PMID><DateRevised><Year>2026</Year><Month>01</Month><Day>18</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><JournalIssue CitedMedium=\"Internet\"><Volume>5</Volume><Issue>3</Issue><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Ageing and neurodegenerative diseases</Title><ISOAbbreviation>Ageing Neurodegener Dis</ISOAbbreviation></Journal><ArticleTitle>Pathogenic mechanisms of amyotrophic lateral sclerosis-linked VAPB P56S mutation in the degeneration of corticospinal motor neurons.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">16</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.20517/and.2025.21</ELocationID><Abstract><AbstractText Label=\"AIM\" NlmCategory=\"UNASSIGNED\">The endoplasmic reticulum (ER)-localized vesicle-associated membrane protein-associated protein B (VAPB) is implicated in many cellular processes, such as ER-organelle tethering, calcium homeostasis, and unfolded protein response. The P56S missense mutation in VAPB has been associated with familial forms of motor neuron diseases such as typical amyotrophic lateral sclerosis (ALS), atypical ALS, and spinal muscular atrophy. However, it has not been determined how the VAPB P56S mutation induces the degeneration of corticospinal motor neurons (CSMNs) in ALS.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">Using homozygous knock-in (KI) mice expressing P56S VAPB, we investigated the mutation's pathogenic impacts and underlying mechanisms on the survival and function of CSMNs. We performed a wide variety of assays to examine the behavioral, histological, cellular, and molecular abnormalities of KI mice.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">Compared with wild-type controls, KI mice showed the downregulated protein level of mutant VAPB, proteinase K-resistant cytoplasmic inclusions of mutant VAPB in CSMNs, abnormal hyperactivity, impaired motor coordination, neuronal loss of CSMNs, and axonal degeneration of pyramidal and corticospinal tracts. Mechanistic studies revealed that the VAPB P56S mutation rendered the mutant protein destabilized and inclusion-prone in cortical neurons, and the proteasomal degradation played a critical role in modulating mutant VAPB's protein level and inclusion formation. In addition, the VAPB P56S mutation disrupted ER-mitochondria contacts, impaired VAPB-PTPIP51 interaction and IP3R-VDAC interaction, elevated cytosolic Ca<sup>2+</sup>, activated CaMKII, and increased CRMP2 phosphorylation. Moreover, the VAPB P56S mutation activated the IRE1-XBP1/p38 mitogen-activated protein kinase (MAPK)/ c-Jun N-terminal kinase (JNK) pathway, increased tau hyperphosphorylation, and upregulated p53 expression and phosphorylation.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"UNASSIGNED\">These findings demonstrate the progressive degeneration of CSMNs induced by VAPB P56S mutation and indicate the involvement of the Ca<sup>2+</sup>-CaMKII-CRMP2 and IRE1-p38 MAPK/JNK-tau/p53 pathways in the pathogenic process.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Yang</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Basic Research Center, Institute for Geriatrics and Rehabilitation, Beijing Geriatric Hospital, Beijing 100095, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zheng</LastName><ForeName>Jiayin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Basic Research Center, Institute for Geriatrics and Rehabilitation, Beijing Geriatric Hospital, Beijing 100095, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Xinyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Basic Research Center, Institute for Geriatrics and Rehabilitation, Beijing Geriatric Hospital, Beijing 100095, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cai</LastName><ForeName>Huaibin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Transgenic Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yu</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Basic Research Center, Institute for Geriatrics and Rehabilitation, Beijing Geriatric Hospital, Beijing 100095, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>Z01 AG000959</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ZIA AG000946</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ageing Neurodegener Dis</MedlineTA><NlmUniqueID>9918232502506676</NlmUniqueID></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Vesicle-associated membrane protein-associated protein B (VAPB)</Keyword><Keyword MajorTopicYN=\"N\">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN=\"N\">corticospinal motor neuron (CSMN)</Keyword><Keyword MajorTopicYN=\"N\">mutation</Keyword><Keyword MajorTopicYN=\"N\">neurodegeneration</Keyword></KeywordList><CoiStatement>Conflicts of interest Huaibin Cai is an Editorial Board member of the journal Ageing and Neurodegenerative Diseases. He was not involved in any steps of editorial processing, notably including reviewer selection, manuscript handling, or decision making. The other authors declared that there are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2026</Year><Month>1</Month><Day>15</Day><Hour>7</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2026</Year><Month>1</Month><Day>15</Day><Hour>7</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2026</Year><Month>1</Month><Day>15</Day><Hour>4</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2026</Year><Month>1</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">41536906</ArticleId><ArticleId IdType=\"mid\">NIHMS2134981</ArticleId><ArticleId IdType=\"pmc\">PMC12797193</ArticleId><ArticleId IdType=\"doi\">10.20517/and.2025.21</ArticleId><ArticleId IdType=\"pii\">16</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Prinz WA, Toulmay A, Balla T. The functional universe of membrane contact sites. Nat Rev Mol Cell Biol. 2020;21:7&#x2013;24.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10619483</ArticleId><ArticleId IdType=\"pubmed\">31732717</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Zhao G, Jia M, et al. Stay in touch with the endoplasmic reticulum. Sci China Life Sci. 2024;67:230&#x2013;57.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38212460</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel EM, Elfmark LA, Stenmark H, Raiborg C. ER as master regulator of membrane trafficking and organelle function. J Cell Biol. 2022:221.</Citation></Reference><Reference><Citation>Domingues N, Pires J, Milosevic I, Raimundo N. Role of lipids in interorganelle communication. Trends Cell Biol. 2025;35:46&#x2013;58.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC11632148</ArticleId><ArticleId IdType=\"pubmed\">38866684</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkkinen I, Their A, Asghar MY, Sree S, Jokitalo E, Airavaara M. Pharmacological regulation of endoplasmic reticulum structure and calcium dynamics: importance for neurodegenerative diseases. Pharmacol Rev. 2023;75:959&#x2013;78.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37127349</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Alvear D, Harnoss JM, Walter P, Ashkenazi A. Homeostasis control in health and disease by the unfolded protein response. Nat Rev Mol Cell Biol. 2025;26:193&#x2013;212.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">39501044</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SE, Levine TP. VAP, a Versatile access point for the endoplasmic reticulum: review and analysis of FFAT-like motifs in the VAPome. Biochim Biophys Acta. 2016;1861:952&#x2013;61.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26898182</ArticleId></ArticleIdList></Reference><Reference><Citation>Neefjes J, Cabukusta B. What the VAP: The expanded VAP family of proteins interacting with FFAT and FFAT-related motifs for interorganellar contact. Contact (Thousand Oaks). 2021;4:25152564211012246.</Citation></Reference><Reference><Citation>James C, Kehlenbach RH. The interactome of the VAP family of proteins: An overview. Cells. 2021;10:1780.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8306308</ArticleId><ArticleId IdType=\"pubmed\">34359948</ArticleId></ArticleIdList></Reference><Reference><Citation>Loewen CJ, Levine TP. A highly conserved binding site in vesicle-associated membrane protein-associated protein (VAP) for the FFAT motif of lipid-binding proteins. J Biol Chem. 2005;280:14097&#x2013;104.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15668246</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Mattia T, Wilhelm LP, Ikhlef S, et al. Identification of MOSPD2, a novel scaffold for endoplasmic reticulum membrane contact sites. EMBO Rep. 2018:19.</Citation></Reference><Reference><Citation>Cabukusta B, Berlin I, van Elsland DM, et al. Human VAPome analysis reveals MOSPD1 and MOSPD3 as membrane contact site proteins interacting with FFAT-related FFNT motifs. Cell Rep. 2020;33:108475.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33296653</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura AL, Mitne-Neto M, Silva HC, et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet. 2004;75:822&#x2013;31.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC1182111</ArticleId><ArticleId IdType=\"pubmed\">15372378</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgese N, Navone F, Nukina N, Yamanaka T. Mutant VAPB: Culprit or innocent bystander of amyotrophic lateral sclerosis? Contact (Thousand Oaks). 2021;4:25152564211022515.</Citation></Reference><Reference><Citation>Kors S, Costello JL, Schrader M. VAP proteins - from organelle tethers to pathogenic host interactors and their role in neuronal disease. Front Cell Dev Biol. 2022;10:895856.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9213790</ArticleId><ArticleId IdType=\"pubmed\">35756994</ArticleId></ArticleIdList></Reference><Reference><Citation>Landers JE, Leclerc AL, Shi L, et al. New VAPB deletion variant and exclusion of VAPB mutations in familial ALS. Neurology. 2008;70:1179&#x2013;85.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18322265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HJ, Anagnostou G, Chai A, et al. Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. J Biol Chem. 2010;285:40266&#x2013;81.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3001007</ArticleId><ArticleId IdType=\"pubmed\">20940299</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, van Es MA, Koppers M, et al. VAPB and C9orf72 mutations in 1 familial amyotrophic lateral sclerosis patient. Neurobiol Aging. 2012;33:2950.e1&#x2013;4.</Citation></Reference><Reference><Citation>Kabashi E, El Oussini H, Bercier V, et al. Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis. Hum Mol Genet. 2013;22:2350&#x2013;60.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23446633</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun YM, Dong Y, Wang J, Lu JH, Chen Y, Wu JJ. A novel mutation of VAPB in one Chinese familial amyotrophic lateral sclerosis pedigree and its clinical characteristics. J Neurol. 2017;264:2387&#x2013;93.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28993872</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura AL, Mitne-Neto M, Silva HC, Oliveira JR, Vainzof M, Zatz M. A novel locus for late onset amyotrophic lateral sclerosis/motor neurone disease variant at 20q13. J Med Genet. 2004;41:315&#x2013;20.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC1735732</ArticleId><ArticleId IdType=\"pubmed\">15060112</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques VD, Barreira AA, Davis MB, et al. Expanding the phenotypes of the Pro56Ser VAPB mutation: proximal SMA with dysautonomia. Muscle Nerve. 2006;34:731&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16967488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosac V, Freitas MR, Prado FM, Nascimento OJ, Bittar C. Familial adult spinal muscular atrophy associated with the VAPB gene: report of 42 cases in Brazil. Arq Neuropsiquiatr. 2013;71:788&#x2013;90.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24212516</ArticleId></ArticleIdList></Reference><Reference><Citation>Di L, Chen H, Da Y, Wang S, Shen XM. Atypical familial amyotrophic lateral sclerosis with initial symptoms of pain or tremor in a Chinese family harboring VAPB-P56S mutation. J Neurol. 2016;263:263&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26566915</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X, Gang Q, Meng L, et al. Peripheral nerve pathology in VAPB-associated amyotrophic lateral sclerosis with dysautonomia in a Chinese family. Clin Neuropathol. 2020;39:282&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32383641</ArticleId></ArticleIdList></Reference><Reference><Citation>Leoni TB, Rezende TJR, Peluzzo TM, et al. Structural brain and spinal cord damage in symptomatic and pre-symptomatic VAPB-related ALS. J Neurol Sci. 2022;434:120126.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35007920</ArticleId></ArticleIdList></Reference><Reference><Citation>Lev S, Ben Halevy D, Peretti D, Dahan N. The VAP protein family: from cellular functions to motor neuron disease. Trends Cell Biol. 2008;18:282&#x2013;90.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18468439</ArticleId></ArticleIdList></Reference><Reference><Citation>Dud&#xe1;s EF, Huynen MA, Lesk AM, Pastore A. Invisible leashes: the tethering VAPs from infectious diseases to neurodegeneration. J Biol Chem. 2021;296:100421.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8005810</ArticleId><ArticleId IdType=\"pubmed\">33609524</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgese N, Iacomino N, Colombo SF, Navone F. The link between VAPB loss of function and amyotrophic lateral sclerosis. Cells. 2021;10:1865.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8392409</ArticleId><ArticleId IdType=\"pubmed\">34440634</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuda H, Han SM, Yang Y, et al. The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell. 2008;133:963&#x2013;77.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2494862</ArticleId><ArticleId IdType=\"pubmed\">18555774</ArticleId></ArticleIdList></Reference><Reference><Citation>Han SM, El Oussini H, Scekic-Zahirovic J, et al. VAPB/ALS8 MSP ligands regulate striated muscle energy metabolism critical for adult survival in caenorhabditis elegans. PLoS Genet. 2013;9:e1003738.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3764199</ArticleId><ArticleId IdType=\"pubmed\">24039594</ArticleId></ArticleIdList></Reference><Reference><Citation>Han SM, Tsuda H, Yang Y, Vibbert J, Cottee P, Lee SJ, Winek J, Haueter C, Bellen HJ, Miller MA. Secreted VAPB/ALS8 major sperm protein domains modulate mitochondrial localization and morphology via growth cone guidance receptors. Dev Cell. 2012; 22(2):348&#x2013;362.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3298687</ArticleId><ArticleId IdType=\"pubmed\">22264801</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz J, Lee SJ, Cole T, et al. The secreted MSP domain of C. elegans VAPB homolog VPR-1 patterns the adult striated muscle mitochondrial reticulum via SMN-1. Development. 2017;144:2175&#x2013;86.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5482996</ArticleId><ArticleId IdType=\"pubmed\">28634272</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamemura K, Chihara T. Multiple functions of the ER-resident VAP and its extracellular role in neural development and disease. J Biochem. 2019;165:391&#x2013;400.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30726905</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Lua S, Tong JS, Song J. Elimination of the native structure and solubility of the hVAPB MSP domain by the Pro56Ser mutation that causes amyotrophic lateral sclerosis. Biochemistry. 2010;49:3887&#x2013;97.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20377183</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J Transforming Cytosolic Proteins into &#x201c;insoluble&#x201d; and membrane-toxic forms triggering diseases/aging by genetic, pathological or environmental factors. Protein Pept Lett. 2017;24:294&#x2013;306.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28190398</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K, Nishimoto I, Aiso S, Matsuoka M. Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8). J Biol Chem. 2006;281:30223&#x2013;33.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16891305</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuling E, Ahmed S, Haasdijk E, et al. Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J Neurosci. 2007;27:9801&#x2013;15.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6672975</ArticleId><ArticleId IdType=\"pubmed\">17804640</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkogkas C, Middleton S, Kremer AM, et al. VAPB interacts with and modulates the activity of ATF6. Hum Mol Genet. 2008;17:1517&#x2013;26.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18263603</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H, Kanekura K, Levine TP, et al. ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. J Neurochem. 2009;108:973&#x2013;85.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19183264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Leal SS, Ben Halevy D, Gomes CM, Lev S. Structural requirements for VAP-B oligomerization and their implication in amyotrophic lateral sclerosis-associated VAP-B(P56S) neurotoxicity. J Biol Chem. 2010;285:13839&#x2013;49.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2859547</ArticleId><ArticleId IdType=\"pubmed\">20207736</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasana E, Fossati M, Ruggiano A, et al. A VAPB mutant linked to amyotrophic lateral sclerosis generates a novel form of organized smooth endoplasmic reticulum. FASEB J. 2010;24:1419&#x2013;30.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20008544</ArticleId></ArticleIdList></Reference><Reference><Citation>Langou K, Moumen A, Pellegrino C, et al. \nAAV-mediated expression of wild-type and ALS-linked mutant VAPB selectively triggers death of motoneurons through a Ca<sup>2+</sup>-dependent ER-associated pathway. J Neurochem. 2010;114:795&#x2013;809.\n</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20477942</ArticleId></ArticleIdList></Reference><Reference><Citation>Moumen A, Virard I, Raoul C. Accumulation of wildtype and ALS-linked mutated VAPB impairs activity of the proteasome. PLoS One. 2011;6:e26066.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3187839</ArticleId><ArticleId IdType=\"pubmed\">21998752</ArticleId></ArticleIdList></Reference><Reference><Citation>Papiani G, Ruggiano A, Fossati M, et al. Restructured endoplasmic reticulum generated by mutant amyotrophic lateral sclerosis-linked VAPB is cleared by the proteasome. J Cell Sci. 2012;125:3601&#x2013;11.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22611258</ArticleId></ArticleIdList></Reference><Reference><Citation>Genevini P, Papiani G, Ruggiano A, Cantoni L, Navone F, Borgese N. Amyotrophic lateral sclerosis-linked mutant VAPB inclusions do not interfere with protein degradation pathways or intracellular transport in a cultured cell model. PLoS One. 2014;9:e113416.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4237408</ArticleId><ArticleId IdType=\"pubmed\">25409455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratnaparkhi A, Lawless GM, Schweizer FE, Golshani P, Jackson GR. A drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism. PLoS One. 2008;3:e2334.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2390852</ArticleId><ArticleId IdType=\"pubmed\">18523548</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest S, Chai A, Sanhueza M, et al. Increased levels of phosphoinositides cause neurodegeneration in a drosophila model of amyotrophic lateral sclerosis. Hum Mol Genet. 2013;22:2689&#x2013;704.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3674808</ArticleId><ArticleId IdType=\"pubmed\">23492670</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaplot K, Pimpale L, Ramalingam B, Deivasigamani S, Kamat SS, Ratnaparkhi GS. SOD1 activity threshold and TOR signalling modulate VAP(P58S) aggregation via reactive oxygen species-induced proteasomal degradation in a drosophila model of amyotrophic lateral sclerosis. Dis Model Mech. 2019;12:dmm033803.</Citation></Reference><Reference><Citation>Thulasidharan A, Garg L, Tendulkar S, Ratnaparkhi GS. Age-dependent dynamics of neuronal VAPB(ALS) inclusions in the adult brain. Neurobiol Dis. 2024;196:106517.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38679111</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudor EL, Galtrey CM, Perkinton MS, et al. Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. Neuroscience. 2010;167:774&#x2013;85.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20188146</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu L, Qiao T, Beers M, et al. Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice. Mol Neurodegener. 2013;8:1.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3538568</ArticleId><ArticleId IdType=\"pubmed\">23281774</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliaga L, Lai C, Yu J, et al. Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons. Hum Mol Genet. 2013;22:4293&#x2013;305.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3792689</ArticleId><ArticleId IdType=\"pubmed\">23771029</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuijpers M, van Dis V, Haasdijk ED, et al. Amyotrophic lateral sclerosis (ALS)-associated VAPB-P56S inclusions represent an ER quality control compartment. Acta Neuropathol Commun. 2013;1:24.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3893532</ArticleId><ArticleId IdType=\"pubmed\">24252306</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P, Guo H, Dreser A, et al. Pathomechanisms of ALS8: altered autophagy and defective RNA binding protein (RBP) homeostasis due to the VAPB P56S mutation. Cell Death Dis. 2021;12:466.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8110809</ArticleId><ArticleId IdType=\"pubmed\">33972508</ArticleId></ArticleIdList></Reference><Reference><Citation>Moustaqim-Barrette A, Lin YQ, Pradhan S, Neely GG, Bellen HJ, Tsuda H. The amyotrophic lateral sclerosis 8 protein, VAP, is required for ER protein quality control. Hum Mol Genet. 2014;23:1975&#x2013;89.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3959812</ArticleId><ArticleId IdType=\"pubmed\">24271015</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka T, Nishiyama R, Shimogori T, Nukina N. Proteomics-based approach identifies altered ER domain properties by ALS-linked VAPB mutation. Sci Rep. 2020;10:7610.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7203144</ArticleId><ArticleId IdType=\"pubmed\">32376919</ArticleId></ArticleIdList></Reference><Reference><Citation>James C, Lenz C, Urlaub H, Kehlenbach RH. Sequestosome 1 Is part of the interaction network of VAPB. Int J Mol Sci. 2021;22:13271.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8707790</ArticleId><ArticleId IdType=\"pubmed\">34948065</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao XK, Sheng ZK, Lu YH, et al. VAPB-mediated ER-targeting stabilizes IRS-1 signalosomes to regulate insulin/IGF signaling. Cell Discov. 2023;9:83.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10394085</ArticleId><ArticleId IdType=\"pubmed\">37528084</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitne-Neto M, Machado-Costa M, Marchetto MC, et al. Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum Mol Genet. 2011;20:3642&#x2013;52.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3159551</ArticleId><ArticleId IdType=\"pubmed\">21685205</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira D, Morales-Vicente DA, Amaral MS, et al. Different gene expression profiles in iPSC-derived motor neurons from ALS8 patients with variable clinical courses suggest mitigating pathways for neurodegeneration. Hum Mol Genet. 2020;29:1465&#x2013;75.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32280986</ArticleId></ArticleIdList></Reference><Reference><Citation>Larroquette F, Seto L, Gaub PL, et al. Vapb/Amyotrophic lateral sclerosis 8 knock-in mice display slowly progressive motor behavior defects accompanying ER stress and autophagic response. Hum Mol Genet. 2015;24:6515&#x2013;29.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4614709</ArticleId><ArticleId IdType=\"pubmed\">26362257</ArticleId></ArticleIdList></Reference><Reference><Citation>Murage B, Tan H, Mashimo T, Jackson M, Skehel PA. Spinal cord neurone loss and foot placement changes in a rat knock-in model of amyotrophic lateral sclerosis Type 8. Brain Commun. 2024;6:fcae184.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC11154649</ArticleId><ArticleId IdType=\"pubmed\">38846532</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng G, Mellor RH, Bernstein M, et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron. 2000;28:41&#x2013;51.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11086982</ArticleId></ArticleIdList></Reference><Reference><Citation>Porrero C, Rubio-Garrido P, Avenda&#xf1;o C, Clasc&#xe1; F. Mapping of fluorescent protein-expressing neurons and axon pathways in adult and developing Thy1-eYFP-H transgenic mice. Brain Res. 2010;1345:59&#x2013;72.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20510892</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziogas NK, Koliatsos VE. Primary Traumatic axonopathy in mice subjected to impact acceleration: a reappraisal of pathology and mechanisms with high-resolution anatomical methods. J Neurosci. 2018;38:4031&#x2013;47.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6705930</ArticleId><ArticleId IdType=\"pubmed\">29567804</ArticleId></ArticleIdList></Reference><Reference><Citation>Miedel CJ, Patton JM, Miedel AN, Miedel ES, Levenson JM. Assessment of spontaneous alternation, novel object recognition and limb clasping in transgenic mouse models of amyloid-&#x3b2; and tau neuropathology. J Vis Exp. 2017.</Citation></Reference><Reference><Citation>Yu J, Lai C, Shim H, et al. Genetic ablation of dynactin p150(Glued) in postnatal neurons causes preferential degeneration of spinal motor neurons in aged mice. Mol Neurodegener. 2018;13:10.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5831668</ArticleId><ArticleId IdType=\"pubmed\">29490687</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos KJ, M&#xf3;rotz GM, Stoica R, et al. VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum Mol Genet. 2012;21:1299&#x2013;311.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3284118</ArticleId><ArticleId IdType=\"pubmed\">22131369</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Schaevitz LR, McConnell SK. Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex. Proc Natl Acad Sci U S A. 2005;102:17184&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC1282569</ArticleId><ArticleId IdType=\"pubmed\">16284245</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Cao C, Ding Y, et al. Plasticity of motor network and function in the absence of corticospinal projection. Exp Neurol. 2015;267:194&#x2013;208.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25792481</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmona LM, Thomas ED, Smith K, Tasic B, Costa RM, Nelson A. Topographical and cell type-specific connectivity of rostral and caudal forelimb corticospinal neuron populations. Cell Rep. 2024;43:113993.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC11100358</ArticleId><ArticleId IdType=\"pubmed\">38551963</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno M, Nakamura Y, Li J, et al. Corticospinal circuits from the sensory and motor cortices differentially regulate skilled movements through distinct spinal interneurons. Cell Rep. 2018;23:1286&#x2013;1300.e7.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6608728</ArticleId><ArticleId IdType=\"pubmed\">29719245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu SA, Li ZJ, Qi L. Endoplasmic reticulum (ER) protein degradation by ER-associated degradation and ER-phagy. Trends Cell Biol. 2025;35:576&#x2013;91.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC12227305</ArticleId><ArticleId IdType=\"pubmed\">39909774</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf3;rotz GM, De Vos KJ, Vagnoni A, Ackerley S, Shaw CE, Miller CC. Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Hum Mol Genet. 2012;21:1979&#x2013;88.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3315205</ArticleId><ArticleId IdType=\"pubmed\">22258555</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica R, De Vos KJ, Paillusson S, et al. ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat Commun. 2014;5:3996.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4046113</ArticleId><ArticleId IdType=\"pubmed\">24893131</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Guerrero SM, Markovinovic A, M&#xf3;rotz GM, Salam S, Noble W, Miller CCJ. Targeting ER-mitochondria signaling as a therapeutic target for frontotemporal dementia and related amyotrophic lateral sclerosis. Front Cell Dev Biol. 2022;10:915931.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9184680</ArticleId><ArticleId IdType=\"pubmed\">35693938</ArticleId></ArticleIdList></Reference><Reference><Citation>Obara CJ, Nixon-Abell J, Moore AS, et al. Motion of VAPB molecules reveals ER-mitochondria contact site subdomains. Nature. 2024;626:169&#x2013;76.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC10830423</ArticleId><ArticleId IdType=\"pubmed\">38267577</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CN, Bayer KU. Studying CaMKII: Tools and standards. Cell Rep. 2024;43:113982.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC11088445</ArticleId><ArticleId IdType=\"pubmed\">38517893</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda R, Hayashi Y, Hell JW. CaMKII: a central molecular organizer of synaptic plasticity, learning and memory. Nat Rev Neurosci. 2022;23:666&#x2013;82.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36056211</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou ST, Jiang SX, Aylsworth A, et al. CaMKII phosphorylates collapsin response mediator protein 2 and modulates axonal damage during glutamate excitotoxicity. J Neurochem. 2009;111:870&#x2013;81.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19735446</ArticleId></ArticleIdList></Reference><Reference><Citation>Moutal A, White KA, Chefdeville A, et al. Dysregulation of CRMP2 post-translational modifications drive its pathological functions. Mol Neurobiol. 2019;56:6736&#x2013;55.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6728212</ArticleId><ArticleId IdType=\"pubmed\">30915713</ArticleId></ArticleIdList></Reference><Reference><Citation>Siwecka N, Rozp&#x119;dek-Kami&#x144;ska W, Wawrzynkiewicz A, Pytel D, Diehl JA, Majsterek I. The structure, activation and signaling of IRE1 and Its role in determining cell fate. Biomedicines. 2021;9:156.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7914947</ArticleId><ArticleId IdType=\"pubmed\">33562589</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JK, Kim NJ. Recent Advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer&#x2019;s disease. Molecules. 2017;22:1287.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6152076</ArticleId><ArticleId IdType=\"pubmed\">28767069</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Kuca K, Wu W, et al. Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases. Alzheimers Dement. 2022;18:152&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34032377</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue J, L&#xf3;pez JM. Understanding MAPK signaling pathways in apoptosis. Int J Mol Sci. 2020;21:2346.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7177758</ArticleId><ArticleId IdType=\"pubmed\">32231094</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortarolo M, Veglianese P, Calvaresi N, et al. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci. 2003;23:180&#x2013;92.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12812752</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C, Atzori C, Piva R, et al. Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice. J Neuropathol Exp Neurol. 2004;63:113&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14989597</ArticleId></ArticleIdList></Reference><Reference><Citation>Holasek SS, Wengenack TM, Kandimalla KK, et al. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice. Brain Res. 2005;1045:185&#x2013;98.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15910777</ArticleId></ArticleIdList></Reference><Reference><Citation>Veglianese P, Lo Coco D, Bao Cutrona M, et al. Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of familial ALS. Mol Cell Neurosci. 2006;31:218&#x2013;31.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16219474</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewil M, dela Cruz VF, Van Den Bosch L, Robberecht W. Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death. Neurobiol Dis. 2007;26:332&#x2013;41.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17346981</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama RR, Fallini C, Gatto R, et al. ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation. Sci Rep. 2017;7:115.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5428330</ArticleId><ArticleId IdType=\"pubmed\">28273913</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuijpers M, Yu KL, Teuling E, Akhmanova A, Jaarsma D, Hoogenraad CC. The ALS8 protein VAPB interacts with the ER-Golgi recycling protein YIF1A and regulates membrane delivery into dendrites. EMBO J. 2013;32:2056&#x2013;72.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3715857</ArticleId><ArticleId IdType=\"pubmed\">23736259</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran D, Chalhoub A, Schooley A, Zhang W, Ngsee JK. A mutation in VAPB that causes amyotrophic lateral sclerosis also causes a nuclear envelope defect. J Cell Sci. 2012;125:2831&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22454507</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YG, Liu N, Miao G, Chen Y, Zhao H, Zhang H. The ER contact proteins VAPA/B interact with multiple autophagy proteins to modulate autophagosome biogenesis. Curr Biol. 2018;28:1234&#x2013;1245.e4.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29628370</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagas NE, Gupta R, Rastegari E, et al. Loss of Activity-induced mitochondrial ATP production underlies the synaptic defects in a drosophila model of ALS. J Neurosci. 2022;42:8019&#x2013;37.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9617612</ArticleId><ArticleId IdType=\"pubmed\">36261266</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong HC, Lang AE, Stein C, Drerup CM. ALS-linked VapB P56S mutation alters neuronal mitochondrial turnover at the synapse. J Neurosci. 2024:44.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>",
  "fetched_at": "2026-01-29T20:00:45.169Z"
}